Listen Now
Topics Covered
- Overview of Chronic Myelogenous Leukemia (CML), in the Context of COVID-19
- Current Standard of Care, New Treatment Approaches & Clinical Trials
- Managing Post Treatment Side Effects/Late Effects
- Adherence: Taking Your Pills on Schedule
- The Importance of Treatment Summaries
- Benefits of Follow-Up Care
- The Importance of Communicating with Your Health Care Team
- Quality-of-Life Concerns
- Questions for Our Panel of Experts
Our Panel of Experts

Michael J. Mauro, MD
Leader, Myeloproliferative Neoplasms Program, Member, Memorial Sloan Kettering Cancer Center, Professor, Weill Cornell Medicine

Neil P. Shah, MD, PhD
Edward S. Ageno Distinguished Professor in Hematology/Oncology, Director, UCSF Molecular Medicine Residency Program, Leader, Hematopoietic Malignancies Program, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco

Elias Jabbour, MD
Professor, Department of Leukemia, Division of Cancer Medicine, The University of Texas, MD Anderson Cancer Center

Carolyn Messner, DSW, BCD, FAPOS, FAOSW
Director of Education and Training, CancerCare
Brochure
You can download the brochure for this workshop
Workshop Date
This workshop was originally recorded on June 09, 2020.